VR: Analysis & Opinions

  1. A Good Deal For Actavis, But Warner Chilcott Goes A ...

    May 21, 2013
    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
  2. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    May 09, 2013
    Teva's partnership with Alexza looks like an expensive gamble.
  3. Schwab's January DARTs Climb - Analyst Blog

    February 15, 2013
    In its monthly market activity report for Jan 2013, The Charles Schwab Corporation (SCHW) reported Daily Average ...
  4. Dr. Reddy's Misses on Both Counts - Analyst Blog

    February 15, 2013
    Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2013 earnings per American Depositary Share (ADS) of 40 ...
  5. Vulcan Reports Mixed 4Q - Analyst Blog

    February 14, 2013
    Vulcan Materials Company (VMC) posted net earnings of 3 cents per share in the fourth quarter of 2012 in contrast to ...
  6. E*TRADE's January DARTs Swing Up - Analyst Blog

    February 13, 2013
    Online brokerage firm, E*TRADE Financial Corporation (ETFC) reported a hike in its Daily Average Revenue Trades ...
  7. D.R. Horton Reaches 52-Week High - Analyst Blog

    February 13, 2013
    One of the largest homebuilders in the U.S., D.R. Horton, Inc (DHI) recently reached a 52-week high of $24.66 on Feb ...
  8. Sanofi Shows Interest in Regeneron - Analyst Blog

    February 12, 2013
    Regeneron Pharmaceuticals, Inc. (REGN) recently announced that it has received a notification under the ...
  9. Perrigo in Expansion Mode - Analyst Blog

    February 12, 2013
    Perrigo Company (PRGO) recently announced that it is set to acquire a UK-based privately held pharmaceutical ...
  10. Brookfield Announces Strategic Deal - Analyst Blog

    February 12, 2013
    Toronto-based Brookfield Asset Management Inc. (BAM) announced the purchase of 19 apartment communities (4,892 ...
  11. TD Ameritrade's January DARTs Rise - Analyst Blog

    February 12, 2013
    TD Ameritrade Holding Corporation (AMTD) - an online brokerage firm - reported a 17% increase in average U.S. trades ...
  12. Warner Chilcott Provides 2013 View - Analyst Blog

    February 11, 2013
    Warner Chilcott (WCRX) recently revealed its financial guidance for 2013. The company expects to earn $3.20-$3.30 ...
  13. Louisiana-Pacific Reports Mixed 4Q - Analyst Blog

    February 11, 2013
    Louisiana-Pacific Corporations (LPX) reported adjusted earnings per share (EPS) from continuing operations of 18 ...
  14. Mixed 4Q at American Capital Agency - Analyst Blog

    February 08, 2013
    American Capital Agency Corp. (AGNC) reported mixed results in fourth quarter 2012. The company's net spread income ...
  15. FDA Nod for Warner Chilcott Drug - Analyst Blog

    February 08, 2013
    Recently, Warner Chilcott plc (WCRX) received encouraging news when the US Food and Drug Administration (FDA) ...
  16. Goldman Benefits from Equity Deal - Analyst Blog

    February 08, 2013
    Amid volatile equity markets and an uncertain global economy, The Goldman Sachs Group Inc. (GS) succeeded in ...
  17. Wider-Than-Expected Loss at Avanir - Analyst Blog

    February 08, 2013
    Avanir Pharmaceuticals, Inc. (AVNR) reported first quarter fiscal 2013 net loss per share of 9 cents, wider than the ...
  18. Lazard Beats Estimates, Expenses Up - Analyst Blog

    February 08, 2013
    Lazard Ltd.'s (LAZ) fourth-quarter 2012 adjusted earnings reached 61 cents per share, significantly beating the ...
  19. KB Home Forays into Texas - Analyst Blog

    February 07, 2013
    One of the leading homebuilding companies in the U.S., KB Home (KBH) recently acquired 56 acres of land in the ...
  20. Sanofi's Diabetes Drug Gets EU Nod - Analyst Blog

    February 07, 2013
    Recently, Sanofi (SNY) received encouraging news with the European Commission (EC) approving its diabetes candidate, ...
Marketplace
Trading Center